Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Disease-modifying antirheumatic drugs are used in virtually all patients with established rheumatoid arthritis. An increasingly large number of new drugs is now available. Furthermore, old therapies are being used in novel ways. Treatment is now begun earlier and patients are rarely left untreated. This report summarises recent developments regarding the drugs currently in use and those that may be available in the near future.


Journal article


Br j clin pract

Publication Date





82 - 86


Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Arthritis, Rheumatoid, Azathioprine, Cyclophosphamide, Cyclosporine, Humans, Immunotherapy, Methotrexate, Sulfasalazine, Treatment Outcome